JJM had three options: (1) distinguish up a meeting with the FDA and argue their case for the treatment and ginmill claims and thereby preserve the opportunity to be first to market, (2) drop the prevention claim and thus increase the chances of organism first to market, or (3) give up the opportunity to be first to market and improve their chances of FDA approval by compendium additional data to support their claims. See Exhibit 3 listing pros and cons of to each one option. Analyses In looking at the potential customers and market for Pepcid AC, it seems the customers have express a ne! ed for a result that lasts longer than the OTC antacids already on the market and that alike help prevent pyrosis symptoms before the start. Pepcid AC could be very belligerent in the traditional OTC antacid valued at $750 million in 1994 if it kindle meet the demands of the consumers that typical exercise these products. According, JJM research approximately 28%-34% of all OTC antacids would recall substituting Pepcid AC for...If you want to get a full essay, order it on our website: BestEssayCheap.com
If you want to get a full essay, visit our page: cheap essay
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.